GSK plc (GSK) vs HCA Healthcare, Inc. (HCA)
GSK and HCA are evenly matched — 8 metrics each of 16.
A side-by-side comparison of GSK plc and HCA Healthcare, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 27, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — GSK vs HCA
growth of $100 · last 15yGSK +36.7%HCA +1162.7%HCA compounded faster
Log scale — wide-divergence pair
GSK HCA
GSK vs HCA: by the numbers
- •GSK is the larger company ($105.20B vs $86.89B market cap).
- •GSK trades at the lower earnings multiple (11.62 vs 13.47 P/E).
- •GSK converts more revenue to profit (17.76% vs 8.89% net margin).
- •HCA grew revenue faster over the past five years (7.73% vs 0.63% CAGR).
- •GSK pays the higher dividend yield (3.51% vs 0.80%).
Which is better, GSK or HCA?
Metric tally: GSK 8 · HCA 8It depends on what you're optimizing for:
ValueGSK(lower P/E)
GrowthHCA(faster 5Y revenue CAGR)
IncomeGSK(higher dividend yield)
QualityHCA(higher ROIC)
Metrics side by side
Valuation
| Metric | GSK | HCA |
|---|---|---|
| P/E ratio | 11.62● | 13.47 |
| Forward P/E | 13.25 | 11.81● |
| P/S ratio | 2.42 | 1.16● |
| P/B ratio | 3.44 | — |
| PEG ratio | 0.02● | 0.57 |
| EV / EBITDA | 8.62● | 8.84 |
| FCF yield | 7.87% | 8.93%● |
Profitability
| Metric | GSK | HCA |
|---|---|---|
| Gross margin | 72.67%● | 34.92% |
| Operating margin | 25.65%● | 15.67% |
| Net margin | 17.76%● | 8.89% |
| ROE | 25.19%● | -112.56% |
| ROIC | 16.61% | 18.53%● |
Dividends
| Metric | GSK | HCA |
|---|---|---|
| Dividend yield | 3.51%● | 0.80% |
| Payout ratio | 24.30% | 10.90% |
Growth (annualized)
| Metric | GSK | HCA |
|---|---|---|
| Revenue CAGR (5Y) | 0.63% | 7.73%● |
| EPS CAGR (5Y) | 14.05% | 20.90%● |
| FCF CAGR (5Y) | -0.35% | 1.92%● |
| Total return CAGR (5Y) | 10.18% | 14.48%● |
Frequently asked
- Which is better, GSK or HCA?
- It depends on your goal. value: GSK (lower P/E); growth: HCA (faster 5Y revenue CAGR); income: GSK (higher dividend yield); quality: HCA (higher ROIC). Across all compared metrics, they are evenly matched.
- Is GSK or HCA cheaper?
- On trailing earnings, GSK is cheaper: GSK trades at a 11.62 P/E and HCA at 13.47.
- Which has grown faster, GSK or HCA?
- Over the past five years, HCA grew revenue faster — GSK at a 0.63% CAGR versus HCA at 7.73%.
- Does GSK or HCA pay a bigger dividend?
- GSK yields 3.51% and HCA yields 0.80% based on trailing dividends and the latest price.
- Is GSK or HCA more profitable?
- GSK runs the higher net margin — GSK at 17.76% versus HCA at 8.89%.
- Which has been the better investment, GSK or HCA?
- Over the past 10-year, HCA delivered the higher annualized total return — GSK at 7.50% versus HCA at 18.54%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
GSK P/E ratioHCA Healthcare P/E ratioGSK dividend yieldHCA Healthcare dividend yieldGSK ROEHCA Healthcare ROEGSK operating marginHCA Healthcare operating marginGSK revenue growthHCA Healthcare revenue growthGSK free cash flowHCA Healthcare free cash flow
GSK & HCA Healthcare appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 27, 2026.